Get started
Author

Patrick Cheung

Observed names: P Cheung, P. Cheung, P.C Cheung, P.C. Cheung, Patrick C. Cheung, Patrick CF. Cheung
Observed institutions: Western University, BC Cancer Agency, Sunnybrook Health Science Centre, University Health Network, Mayo Clinic, University of Ottawa, University of Calgary, University of Toronto, Juravinski Cancer Centre, Montreal General Hospital, Ottawa Hospital, Princess Margaret Cancer Centre, Hôpital Maisonneuve-Rosemont, Hospital de São João, CancerCare Manitoba, Amgen (United Kingdom), Dr. H. Bliss Murphy Cancer Centre, Sunnybrook Hospital, Sunnybrook Research Institute, Cross Cancer Institute, Canadian Cancer Trials Group, Odette Cancer Centre, University of Manitoba, McGill University, Université de Montréal, McMaster University
OpenAlex ID: A5111828535
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
2017 · Charles N. Catton, Himu Lukka, et al. · Journal of Clinical Oncology · 741
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
2019 · Amar U. Kishan, Audrey Dang, et al. · JAMA Network Open · 336
PDF
Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review
2008 · Alysa Fairchild, Kristin Harris, et al. · Journal of Clinical Oncology · 273
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study
2014 · Robert K Nam, Patrick Cheung, et al. · The Lancet Oncology · 232
Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes
2013 · Andrew Loblaw, Patrick Cheung, et al. · Radiotherapy and Oncology · 165
Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study
2016 · Christopher J D Wallis, Kirk Lo, et al. · The Lancet Diabetes & Endocrinology · 163
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
2018 · Anastasia Oikonomou, Farzad Khalvati, et al. · Scientific Reports · 150
PDF
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
2020 · Gerard Morton, Merrylee McGuffin, et al. · Radiotherapy and Oncology · 134
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
2021 · Patrick Cheung, Samir Patel, et al. · European Urology · 130
Assessing the Role of Volumetric Modulated Arc Therapy (VMAT) Relative to IMRT and Helical Tomotherapy in the Management of Localized, Locally Advanced, and Post-Operative Prostate Cancer
2011 · Melanie T.M. Davidson, Samuel J. Blake, et al. · International Journal of Radiation Oncology*Biology*Physics · 110
Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of Life
2009 · Gerard C. Morton, D. Andrew Loblaw, et al. · International Journal of Radiation Oncology*Biology*Physics · 98
Stereotactic body radiotherapy for oligoprogressive cancer
2016 · Patrick Cheung · British Journal of Radiology · 96
Is single fraction 15Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
2011 · Gerard Morton, Andrew Loblaw, et al. · Radiotherapy and Oncology · 92
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy
2016 · Gerard Morton, Hans T. Chung, et al. · Radiotherapy and Oncology · 89
A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors
2010 · Kathy Han, Patrick Cheung, et al. · Radiotherapy and Oncology · 83
Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer
2005 · Patrick Cheung, Katharina Sixel, et al. · International Journal of Radiation Oncology*Biology*Physics · 82
Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial
2018 · Harvey C. Quon, Aldrich Ong, et al. · Radiotherapy and Oncology · 80
Phase I/II Study of a Five-fraction Hypofractionated Accelerated Radiotherapy Treatment for Low-risk Localised Prostate Cancer: Early Results of pHART3
2008 · C.I. Tang, D.A. Loblaw, et al. · Clinical Oncology · 80
Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25
2014 · P. Cheung, S. Faria, et al. · JNCI Journal of the National Cancer Institute · 79
The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
2018 · Joe H. Chang, Ian Poon, et al. · Radiotherapy and Oncology · 74
Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter
2017 · Joelle Helou, Isabelle Thibault, et al. · International Journal of Radiation Oncology*Biology*Physics · 68
Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials
2016 · H Bindu Musunuru, Harvey Quon, et al. · Radiotherapy and Oncology · 67
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
2018 · Hima Bindu Musunuru, Laura D'Alimonte, et al. · International Journal of Radiation Oncology*Biology*Physics · 66
Health-Related Quality of Life After Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Prostate Cancer
2010 · Gerard C. Morton, D. Andrew Loblaw, et al. · International Journal of Radiation Oncology*Biology*Physics · 66
Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases
2018 · Darby Erler, Drew Brotherston, et al. · Radiotherapy and Oncology · 65
Works count: 330
Citation count: 6,649
H-index: 43
I10-index: 120
Year
Topic
Type